Nur Gizem Elipek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nur Gizem Elipek has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Emrah Uğuz
Department of Cardiovascular Surgery, Ankara Yıldırım Beyazıt University Faculty of Medicine, 06010 Ankara, Türkiye, Turkey (Türkiye)
3 shared publications - Kemal Eşref Erdoğan
Department of Cardiovascular Surgery, Ankara Yıldırım Beyazıt University Faculty of Medicine, 06010 Ankara, Türkiye
3 shared publications - Muhammet Fethi Sağlam
Department of Cardiovascular Surgery, Ankara Yıldırım Beyazıt University Faculty of Medicine, 06010 Ankara, Türkiye, Turkey (Türkiye)
3 shared publications - Murat Yücel
Department of Cardiovascular Surgery, Ankara Bilkent City Hospital, Ankara 06800, Türkiye
3 shared publications - Hakan Çomaklı
Ankara Bilkent City Hospital, Cardiovascular Surgery Clinic, Ankara, Türkiye
2 shared publications - Ömer Abdullah Yavuz
Department of Cardiovascular Surgery, Ankara Bilkent City Hospital, Ankara 06800, Türkiye
2 shared publications
Latest Publications
- Open Access
- 13 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 560
Diabetic Peripheral Arterial Disease Versus Thromboangiitis Obliterans: A Multidimensional Comparison of Clinical Phenotype, Biomarkers, and Outcomes
Objective: This study aimed to compare thromboangiitis obliterans (TAO) and diabetic peripheral vascular disease (DPVD), the two major causes of distal limb ischemia, within a single analytical framework. The comparison was not limited to practical biomarkers that could support differential diagnosis but was based on multidimensional parameters that determine the clinical spectrum and prognosis. The two cohorts were systematically evaluated in terms of demographics and comorbidity burden, clinical presentation and limb involvement pattern, ulcer prevalence and localization, real-life treatment strategies (medical, endovascular, and surgical), and hard clinical endpoints (major/minor amputation, hospitalization, and all-cause mortality). DPVD was phenotyped according to the lesion level as isolated distal, isolated proximal, or multilevel. Within this framework, the isolated distal diabetic peripheral vascular disease (d-DPVD) subgroup was analyzed to determine how it differs from TAO in terms of clinical course, treatment patterns, and outcomes, despite the distal anatomical similarity. Methods: In this single-center retrospective cohort study, conducted between June 2019 and June 2025, 120 non-diabetic patients who met the angiographic TAO criteria were compared with 395 patients with DPVD with infrapopliteal/pedal atherosclerotic involvement. Clinical characteristics, ulcer topography, treatment strategies, and outcomes were recorded. The discriminatory value of the blood count and lipid-based inflammatory/atherogenic indices were evaluated using logistic regression and receiver operating characteristic (ROC) curve analyses. Additionally, a separate subgroup analysis was performed for the d-DPVD subgroup, which was considered the closest to the TAO phenotype in this study design. Results: Patients with DPVD were significantly older than those with TAO (61.1 ± 12.1 vs. 39.7 ± 7.9 years; p < 0.001), and male predominance was more pronounced in the TAO group (94.2% vs. 84.8%). Compared with TAO, DPVD was associated with a higher cardiometabolic comorbidity burden and increased inflammatory and atherogenic indices. Although the overall ulcer prevalence was comparable, DPVD more frequently presented with plantar or proximal ulcers confined to a single extremity, whereas TAO was characterized by bilateral or multi-extremity involvement and distal acral ulceration. Antiplatelet and statin therapy, revascularization, and rates of major amputation, all-cause mortality, and hospitalization were higher in patients with DPVD (all p < 0.05). On multivariate analysis, age, cumulative smoking exposure, SIRI, and CRI-I independently distinguished DPVD from TAO (all p < 0.05). In the isolated distal DPVD subgroup, despite similar distal anatomy, inflammatory/atherogenic burden, and overall clinical risk remained adverse. Conclusions: TAO and DPVD are two distinct phenotypes with different pathobiologies and prognoses, despite similar distal ischemia presentations. Simple inflammatory and atherogenic composite indices, evaluated in conjunction with clinical/ulcer patterns, may support the differential diagnosis and risk stratification of patients with peripheral arterial disease (PAD). However, prospective multicenter validation of these findings is required to confirm the results.
- 13 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 560
Open AccessDiabetic Peripheral Arterial Disease Versus Thromboangiitis Obliterans: A Multidimensional Comparison of Clinical Phenotype, Biomarkers, and Outcomes
Objective: This study aimed to compare thromboangiitis obliterans (TAO) and diabetic peripheral vascular disease (DPVD), the two major causes of distal limb ischemia, within a single analytical framework. The comparison was not limited to practical biomarkers that could support differential diagnosis but was based on multidimensional parameters that determine the clinical spectrum and prognosis. The two cohorts were systematically evaluated in terms of demographics and comorbidity burden, clinical presentation and limb involvement pattern, ulcer prevalence and localization, real-life treatment strategies (medical, endovascular, and surgical), and hard clinical endpoints (major/minor amputation, hospitalization, and all-cause mortality). DPVD was phenotyped according to the lesion level as isolated distal, isolated proximal, or multilevel. Within this framework, the isolated distal diabetic peripheral vascular disease (d-DPVD) subgroup was analyzed to determine how it differs from TAO in terms of clinical course, treatment patterns, and outcomes, despite the distal anatomical similarity. Methods: In this single-center retrospective cohort study, conducted between June 2019 and June 2025, 120 non-diabetic patients who met the angiographic TAO criteria were compared with 395 patients with DPVD with infrapopliteal/pedal atherosclerotic involvement. Clinical characteristics, ulcer topography, treatment strategies, and outcomes were recorded. The discriminatory value of the blood count and lipid-based inflammatory/atherogenic indices were evaluated using logistic regression and receiver operating characteristic (ROC) curve analyses. Additionally, a separate subgroup analysis was performed for the d-DPVD subgroup, which was considered the closest to the TAO phenotype in this study design. Results: Patients with DPVD were significantly older than those with TAO (61.1 ± 12.1 vs. 39.7 ± 7.9 years; p < 0.001), and male predominance was more pronounced in the TAO group (94.2% vs. 84.8%). Compared with TAO, DPVD was associated with a higher cardiometabolic comorbidity burden and increased inflammatory and atherogenic indices. Although the overall ulcer prevalence was comparable, DPVD more frequently presented with plantar or proximal ulcers confined to a single extremity, whereas TAO was characterized by bilateral or multi-extremity involvement and distal acral ulceration. Antiplatelet and statin therapy, revascularization, and rates of major amputation, all-cause mortality, and hospitalization were higher in patients with DPVD (all p < 0.05). On multivariate analysis, age, cumulative smoking exposure, SIRI, and CRI-I independently distinguished DPVD from TAO (all p < 0.05). In the isolated distal DPVD subgroup, despite similar distal anatomy, inflammatory/atherogenic burden, and overall clinical risk remained adverse. Conclusions: TAO and DPVD are two distinct phenotypes with different pathobiologies and prognoses, despite similar distal ischemia presentations. Simple inflammatory and atherogenic composite indices, evaluated in conjunction with clinical/ulcer patterns, may support the differential diagnosis and risk stratification of patients with peripheral arterial disease (PAD). However, prospective multicenter validation of these findings is required to confirm the results.
- Open Access
- 23 January 2026
- Published by MDPI AG in Preprints.org
Diabetic Peripheral Arterial Disease versus Thromboangiitis Obliterans: A Multidimensional Comparison of Clinical Phenotype, Biomarkers, and Outcomes
Objective: This study aimed to compare thromboangiitis obliterans (TAO) and diabetic peripheral vascular disease (DPVD), the two major causes of distal limb ischemia, within a single analytical framework. The comparison was not limited to practical biomarkers that could support differential diagnosis; it was based on multidimensional parameters that determine the clinical spectrum and prognosis. The two cohorts were systematically evaluated in terms of demographics and comorbidity burden, clinical presentation and limb involvement pattern, ulcer prevalence and localization, real-life treatment strategies (medical, endovascular, and surgical), and hard clinical endpoints (major/minor amputation, hospitalization, and all-cause mortality). DPVD was phenotyped according to the lesion level as isolated distal, isolated proximal, or multilevel. Within this framework, the isolated distal diabetic peripheral vascular disease (d-DPVD) subgroup was analyzed to determine how it differs from TAO in terms of clinical course, treatment patterns, and outcomes, despite the distal anatomical similarity. Methods: In this single-center retrospective cohort study, 120 non-diabetic patients who met the angiographic TAO criteria were compared with 395 patients with DPVD with infrapopliteal/pedal atherosclerotic involvement. The clinical characteristics, ulcer topography, treatment strategies, and outcomes were recorded. The discriminatory value of blood count and lipid-based inflammatory/atherogenic indices was evaluated using logistic regression and receiver operating characteristic (ROC) curve analyses. Additionally, a separate subgroup analysis was performed for the d-DPVD subgroup, which was considered the closest to the TAO phenotype in this study. Results: DPVD was characterized by older age, higher cardiometabolic comorbidity burden, and higher inflammatory and atherogenic indices than TAO. While ulcer prevalence was similar, the distribution differed: DPVD predominantly involved plantar/proximal ulcers in a single extremity, whereas TAO more frequently involved bilateral/multiple extremities and distal acral ulcers. Antiplatelet/statin use and revascularization were more common in patients with DPVD, and major amputation, all-cause mortality, and hospitalization rates were also higher. In multivariate analyses, age, cumulative smoking exposure, SIRI, and CRI-I distinguished DPVD from TAO independently. In the d-DPVD (isolated distal) subgroup, despite a similar distal anatomical distribution, the inflammatory/atherogenic burden and clinical risk were more unfavorable. Conclusion: TAO and DPVD are two distinct phenotypes with different pathobiologies and prognoses, despite similar distal ischemia presentations. Simple inflammatory and atherogenic composite indices, evaluated in conjunction with clinical/ulcer patterns, may support differential diagnosis and risk stratification in patients with PAD. However, prospective multicenter validation of these findings is required to confirm our results.
- 23 January 2026
- Published by MDPI AG in Preprints.org
Open AccessDiabetic Peripheral Arterial Disease versus Thromboangiitis Obliterans: A Multidimensional Comparison of Clinical Phenotype, Biomarkers, and Outcomes
Objective: This study aimed to compare thromboangiitis obliterans (TAO) and diabetic peripheral vascular disease (DPVD), the two major causes of distal limb ischemia, within a single analytical framework. The comparison was not limited to practical biomarkers that could support differential diagnosis; it was based on multidimensional parameters that determine the clinical spectrum and prognosis. The two cohorts were systematically evaluated in terms of demographics and comorbidity burden, clinical presentation and limb involvement pattern, ulcer prevalence and localization, real-life treatment strategies (medical, endovascular, and surgical), and hard clinical endpoints (major/minor amputation, hospitalization, and all-cause mortality). DPVD was phenotyped according to the lesion level as isolated distal, isolated proximal, or multilevel. Within this framework, the isolated distal diabetic peripheral vascular disease (d-DPVD) subgroup was analyzed to determine how it differs from TAO in terms of clinical course, treatment patterns, and outcomes, despite the distal anatomical similarity. Methods: In this single-center retrospective cohort study, 120 non-diabetic patients who met the angiographic TAO criteria were compared with 395 patients with DPVD with infrapopliteal/pedal atherosclerotic involvement. The clinical characteristics, ulcer topography, treatment strategies, and outcomes were recorded. The discriminatory value of blood count and lipid-based inflammatory/atherogenic indices was evaluated using logistic regression and receiver operating characteristic (ROC) curve analyses. Additionally, a separate subgroup analysis was performed for the d-DPVD subgroup, which was considered the closest to the TAO phenotype in this study. Results: DPVD was characterized by older age, higher cardiometabolic comorbidity burden, and higher inflammatory and atherogenic indices than TAO. While ulcer prevalence was similar, the distribution differed: DPVD predominantly involved plantar/proximal ulcers in a single extremity, whereas TAO more frequently involved bilateral/multiple extremities and distal acral ulcers. Antiplatelet/statin use and revascularization were more common in patients with DPVD, and major amputation, all-cause mortality, and hospitalization rates were also higher. In multivariate analyses, age, cumulative smoking exposure, SIRI, and CRI-I distinguished DPVD from TAO independently. In the d-DPVD (isolated distal) subgroup, despite a similar distal anatomical distribution, the inflammatory/atherogenic burden and clinical risk were more unfavorable. Conclusion: TAO and DPVD are two distinct phenotypes with different pathobiologies and prognoses, despite similar distal ischemia presentations. Simple inflammatory and atherogenic composite indices, evaluated in conjunction with clinical/ulcer patterns, may support differential diagnosis and risk stratification in patients with PAD. However, prospective multicenter validation of these findings is required to confirm our results.
- Open Access
- 26 February 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (5) , 567
A Retrospective Analysis of Standardized Gradient Calculations for Evaluating Patient–Prosthesis Mismatch Following Mechanical Aortic Valve Replacement
Background: Aortic stenosis (AS) is one of the most common valvular heart diseases, particularly in the elderly, with a prevalence of approximately 3% in individuals over 75 years of age. Aortic valve replacement (AVR) remains the standard treatment, yet postoperative hemodynamic assessment is often complicated by variations in prosthetic valve size, left ventricular ejection fraction (LVEF), effective orifice area (EOA), and body surface area (BSA). These factors significantly influence prosthetic valve function and contribute to patient–prosthesis mismatch (PPM), which has been associated with worse clinical outcomes. Traditional transvalvular gradient measurements often fail to account for these patient-specific variables. This study introduces a novel approach to standardized gradient calculations, aiming to enhance the accuracy and comparability of prosthetic valve assessments. Methods: A retrospective analysis was conducted on 115 patients who underwent mechanical AVR at a single center. Patients were categorized into three groups based on the prosthetic valve type: St. Jude Medical (SJM) HP (n = 31); SJM Regent (n = 54); and those who underwent aortic root enlargement (ARE) (n = 30). Preoperative and postoperative transthoracic echocardiography (TTE) was performed to measure conventional and standardized transvalvular gradients. Four novel standardized gradient calculations were developed to adjust for individual hemodynamic differences, improving the accuracy of prosthetic valve function assessment. Results: Standardized gradient calculations demonstrated significant differences between prosthesis types. Postoperative standardized gradients were significantly higher in the SJM HP group compared to the SJM Regent and aortic-root-enlargement groups (p < 0.001, p < 0.05). The lowest standardized gradients were observed in patients who received the SJM Regent prostheses (p < 0.05). Although conventional measurements showed no significant differences, standardized calculations revealed that patients with 19 mm prostheses exhibited significantly higher transvalvular gradients than those with 21 mm prostheses (p < 0.05), emphasizing the clinical importance of prosthesis size in postoperative hemodynamics. Conclusions: Standardized gradient calculations provide a more objective, reliable, and patient-specific assessment of prosthetic valve function by minimizing interpatient variability. This approach improves the detection of patient–prosthesis mismatch and optimizes postoperative hemodynamic evaluation, potentially leading to better prosthesis selection and surgical decision-making. However, further validation is required in larger cohorts before these methods can be widely adopted into clinical practice. Future studies should assess their impact on long-term clinical outcomes, including left ventricular remodeling and patient survival.
- 26 February 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (5) , 567
Open AccessA Retrospective Analysis of Standardized Gradient Calculations for Evaluating Patient–Prosthesis Mismatch Following Mechanical Aortic Valve Replacement
Background: Aortic stenosis (AS) is one of the most common valvular heart diseases, particularly in the elderly, with a prevalence of approximately 3% in individuals over 75 years of age. Aortic valve replacement (AVR) remains the standard treatment, yet postoperative hemodynamic assessment is often complicated by variations in prosthetic valve size, left ventricular ejection fraction (LVEF), effective orifice area (EOA), and body surface area (BSA). These factors significantly influence prosthetic valve function and contribute to patient–prosthesis mismatch (PPM), which has been associated with worse clinical outcomes. Traditional transvalvular gradient measurements often fail to account for these patient-specific variables. This study introduces a novel approach to standardized gradient calculations, aiming to enhance the accuracy and comparability of prosthetic valve assessments. Methods: A retrospective analysis was conducted on 115 patients who underwent mechanical AVR at a single center. Patients were categorized into three groups based on the prosthetic valve type: St. Jude Medical (SJM) HP (n = 31); SJM Regent (n = 54); and those who underwent aortic root enlargement (ARE) (n = 30). Preoperative and postoperative transthoracic echocardiography (TTE) was performed to measure conventional and standardized transvalvular gradients. Four novel standardized gradient calculations were developed to adjust for individual hemodynamic differences, improving the accuracy of prosthetic valve function assessment. Results: Standardized gradient calculations demonstrated significant differences between prosthesis types. Postoperative standardized gradients were significantly higher in the SJM HP group compared to the SJM Regent and aortic-root-enlargement groups (p < 0.001, p < 0.05). The lowest standardized gradients were observed in patients who received the SJM Regent prostheses (p < 0.05). Although conventional measurements showed no significant differences, standardized calculations revealed that patients with 19 mm prostheses exhibited significantly higher transvalvular gradients than those with 21 mm prostheses (p < 0.05), emphasizing the clinical importance of prosthesis size in postoperative hemodynamics. Conclusions: Standardized gradient calculations provide a more objective, reliable, and patient-specific assessment of prosthetic valve function by minimizing interpatient variability. This approach improves the detection of patient–prosthesis mismatch and optimizes postoperative hemodynamic evaluation, potentially leading to better prosthesis selection and surgical decision-making. However, further validation is required in larger cohorts before these methods can be widely adopted into clinical practice. Future studies should assess their impact on long-term clinical outcomes, including left ventricular remodeling and patient survival.
- Open Access
- 1 November 2024
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 32 (4) , 108-109
[MEP-12] Rare and Catastrophic Complication After Bentall Operation: Right Coronary Artery Button Pseudoaneursym Repaired with Modified Cabrol Technique
Coronary artery pseudoaneurysm is a rare but fatal complication that can be seen following the Bentall operation. Modified techniques have reduced these complications but they have not completely eliminated them. In this case report, we presented a 65-year-old female patient who underwent a Bentall procedure in 2012 and endovascular coil repair of a right coronary artery button pseudoaneurysm in 2016. Right femoral artery and vein cannulation was performed, and systemic cooling was started. Cardiopulmonary bypass was instituted, and the patient was cooled to 18°C. Deep hypothermic circulatory arrest was started, and resternotomy was performed (deep hypothermic circulatory arrest duration was 7 min). The aneurysm sac was opened. Of the coronary buttons the left main coronary artery orifice was not suitable for direct reimplantation to the new ascending graft, reimplantation was performed with the modified Cabrol technique using an 8-mm Dacron graft. The right coronary artery orifice was primarily closed, and bypass was performed on the Cabrol graft with a saphenous vein graft. The patient was rewarmed and weaned off cardiopulmonary bypass without complication. Intraoperative control fiberoptic bronchoscopy and transesophageal echocardiography showed that the trachea and pulmonary artery compression were completely eliminated. The patient was extubated on time during the intensive care course and made an uneventful recovery. Coronary button pseudoaneurysm complication after modified Bentall surgery requires urgent surgical repair. The modified Cabrol technique can be a lifesaver in such complications and redo cases. Although there are authors who recommend interventional methods first in this complication, we believe that early surgical intervention is more appropriate as it will become more complicated over time.
- 1 November 2024
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 32 (4) , 108-109
Open Access[MEP-12] Rare and Catastrophic Complication After Bentall Operation: Right Coronary Artery Button Pseudoaneursym Repaired with Modified Cabrol Technique
Coronary artery pseudoaneurysm is a rare but fatal complication that can be seen following the Bentall operation. Modified techniques have reduced these complications but they have not completely eliminated them. In this case report, we presented a 65-year-old female patient who underwent a Bentall procedure in 2012 and endovascular coil repair of a right coronary artery button pseudoaneurysm in 2016. Right femoral artery and vein cannulation was performed, and systemic cooling was started. Cardiopulmonary bypass was instituted, and the patient was cooled to 18°C. Deep hypothermic circulatory arrest was started, and resternotomy was performed (deep hypothermic circulatory arrest duration was 7 min). The aneurysm sac was opened. Of the coronary buttons the left main coronary artery orifice was not suitable for direct reimplantation to the new ascending graft, reimplantation was performed with the modified Cabrol technique using an 8-mm Dacron graft. The right coronary artery orifice was primarily closed, and bypass was performed on the Cabrol graft with a saphenous vein graft. The patient was rewarmed and weaned off cardiopulmonary bypass without complication. Intraoperative control fiberoptic bronchoscopy and transesophageal echocardiography showed that the trachea and pulmonary artery compression were completely eliminated. The patient was extubated on time during the intensive care course and made an uneventful recovery. Coronary button pseudoaneurysm complication after modified Bentall surgery requires urgent surgical repair. The modified Cabrol technique can be a lifesaver in such complications and redo cases. Although there are authors who recommend interventional methods first in this complication, we believe that early surgical intervention is more appropriate as it will become more complicated over time.